Galenica AG
GALNF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.96B
Close$
$120.53
21.2% upside
Current Fair Value
21.2% upsideUndervalued by 21.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $4.96 Billion |
|---|---|
| Enterprise Value | $6.04 Billion |
| Annual dividend | $1.59 |
| Dividend yield | 2.84% |
| Earnings per Share | $3.63 |
| Beta | 0.31 |
| Outstanding Shares | 49,889,473 |
Return
| Return on Equity | 24.89% |
|---|---|
| Return on Assets | 10.57% |
| Return on Invested Capital | 18.96% |
Valuation & Multiples
| P/E Ratio | 27.62 |
|---|---|
| PEG | -111.22 |
| Price to Sales | 0.6 |
| Price to Book Ratio | 3.55 |
| Enterprise Value to Revenue | 0.73 |
| Enterprise Value to EBIT | 13.96 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 0.8 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$2.39
Consensus analyst estimateRevenue Estimate
$2.63 B
Consensus analyst estimateNext Earnings Call
Expected Date
March 9, 2027
EPS Estimate
$2.25
Consensus analyst estimateRevenue Estimate
$2.71 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Galenica AG
6,558 employees
CEO: Marc Werner
Galenica AG operates as a prominent healthcare services provider, delivering solutions across Switzerland and internationally. Its operations are structured into two core divisions: Products & Care, and Logistics & Information Technology...